CDC26P1

Across TCGA pan-cancer cohorts, CDC26P1 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated CDC26P1 data layer.

The strongest signal is observed in brain lower grade glioma (LGG), where higher CDC26P1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CDC26P1 expression acts as an unfavorable survival marker, although some lineages such as COAD and SKCM show a favorable association.

LGG, BLCA, and COAD are the cancer types where CDC26P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LGG	OS	Quartile	All	0.231	0.653	<.001	26	view →
BLCA	DFS	Tertile	IV	0.381	0.590	.006	23	view →
COAD	OS	Quartile	IV	0.871	0.241	.010	20	view →
SKCM	OS	Tertile	IV	1.000	0.211	.006	11	view →
READ	DFS	Quartile	All	0.925	0.763	.019	9	view →
PAAD	OS	Quartile	All	0.701	0.409	.015	7	view →
KICH	OS	Tertile	III,IV	0.812	0.237	.011	6	view →
CHOL	DFS	Median	All	0.643	0.207	.044	6	view →
DLBC	DFS	Median	IV	0.195	0.923	.038	5	view →
KIRC	OS	Median	II,III,IV	0.634	0.461	.017	4	view →
LUSC	OS	Median	All	0.711	0.808	.017	4	view →
UCEC	DFS	Quartile	All	0.617	0.776	.032	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

CDC26P1–LGG (OS)

Open the LGG breakdown →